← Leaderboards
Huda Salman
Indiana University Indianapolis
$3,119,132
Attributed
$3,119,132
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $788.1K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
FDA$3,119,132 · 1
By mechanism
R01$3,119,132 · 1
Top collaborators
No co-investigators on record.
Grant awards (5)
CD4 Redirected Chimeric Antigen Receptor T Cell Therapy for CD4 Positive T Cell Neoplasms$756,574
R01 · FY2025 · FD · contact PI
CD4 Redirected Chimeric Antigen Receptor T Cell Therapy for CD4 Positive T Cell Neoplasms$788,134
R01 · FY2024 · FD · contact PI
CD4 Redirected Chimeric Antigen Receptor T Cell Therapy for CD4 Positive T Cell Neoplasms$787,515
R01 · FY2023 · FD · contact PI
CD4 Redirected Chimeric Antigen Receptor T Cell Therapy for CD4 Positive T Cell Neoplasms$526,876
R01 · FY2020 · FD · contact PI
CD4 Redirected Chimeric Antigen Receptor T Cell Therapy for CD4 Positive T Cell Neoplasms$260,033
R01 · FY2020 · FD · contact PI